Carcinoid syndrome MRI

Revision as of 20:17, 30 September 2015 by Parminder Dhingra (talk | contribs)
Jump to navigation Jump to search

Carcinoid syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Carcinoid Syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Carcinoid syndrome MRI On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Carcinoid syndrome MRI

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Carcinoid syndrome MRI

CDC on Carcinoid syndrome MRI

Carcinoid syndrome MRI in the news

Blogs on Carcinoid syndrome MRI

Directions to Hospitals Treating Carcinoid syndrome

Risk calculators and risk factors for Carcinoid syndrome MRI

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]

Overview

On abdominal MRI, carcinoid tumor is characterized by nodular mass originating from the bowel wall or regional uniform bowel wall thickening with moderate intense enhancement on postgadolinium T1-weighted fat-suppressed images. Abdominal MRI scan may be performed to detect metastases of carcinoid syndrome to liver and mesentery.

MRI

On abdominal MRI, carcinoid syndrome is characterized by:[1]

  • Nodular mass originating from the bowel wall or regional uniform bowel wall thickening with moderate intense enhancement on postgadolinium T1-weighted fat-suppressed images.
  • Mesenteric metastases presented as nodular masses with mesenteric stranding.
  • Liver metastases may show hypointense precontrast T1- and hyperintense T2-weighted images.
  • Liver metastases are commonly hypervascular.

References

  1. Bader TR, Semelka RC, Chiu VC, Armao DM, Woosley JT (2001). "MRI of carcinoid tumors: spectrum of appearances in the gastrointestinal tract and liver". J Magn Reson Imaging. 14 (3): 261–9. PMID 11536403.

Template:WH Template:WS